Home > Boards > US Listed > Medical - Drugs > Abbvie (ABBV)

you called it

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
[SMART MONEY]  Member Profile
Member Level 
Followed By 3,270
Posts 119,178
Boards Moderated 17
Alias Born 08/05/09
160x600 placeholder
Form 8.3 - [Allergan plc] Dow Jones News - 12/13/2019 9:55:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 12/12/2019 10:09:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 12/11/2019 9:35:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 12/10/2019 9:58:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 12/9/2019 9:53:00 AM
Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay GlobeNewswire Inc. - 12/9/2019 8:00:10 AM
AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics PR Newswire (US) - 12/9/2019 8:00:00 AM
New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYX... PR Newswire (US) - 12/8/2019 7:30:00 AM
More than Seven-Year Analysis of Early Treatment with IMBRUVICA® (ibrutinib) Monotherapy Showed Improved Progression-Free Su... PR Newswire (US) - 12/7/2019 9:00:00 AM
Extended Follow-up Phase 3 Data Underscore Sustained Efficacy and Safety of IMBRUVICA® (ibrutinib) in the Treatment of Chron... PR Newswire (US) - 12/7/2019 7:33:00 AM
IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Data Show High Rates of Disease Clearance in Pr... PR Newswire (US) - 12/7/2019 7:30:00 AM
Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting GlobeNewswire Inc. - 12/6/2019 4:30:10 PM
Form 8.3 - [Allergan plc] Dow Jones News - 12/6/2019 9:49:00 AM
AbbVie conclut une entente avec l'Alliance pancanadienne pharmaceutique (APP) relativement à SKYRIZI[MC] (risankizumab) pour... PR Newswire (Canada) - 12/6/2019 6:08:00 AM
AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for SKYRIZI™ (risankizumab) for the Treatm... PR Newswire (Canada) - 12/6/2019 6:08:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 12/5/2019 9:39:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 12/4/2019 9:54:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 12/3/2019 10:43:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 12/2/2019 9:59:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 11/27/2019 10:04:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 11/26/2019 10:07:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 11/25/2019 9:13:00 AM
Form 8.3 - [Allergan Plc] Dow Jones News - 11/22/2019 10:03:00 AM
Harpoon Therapeutics Shares Rise on Expanded Deal With AbbVie Dow Jones News - 11/21/2019 12:35:00 PM
Form 8.3 - [Allergan plc] Dow Jones News - 11/21/2019 9:45:00 AM
[SMART MONEY] Member Level  Thursday, 06/27/19 09:13:10 PM
Re: $Pistol Pete$ post# 464
Post # of 513 
you called it


you earn the props


Ugotta give credit

to where credit is due

imo



Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist